Literature DB >> 8734460

Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.

T Niwa1.   

Abstract

A number of organic acids including phenols are accumulated in plasma of uremic patients because of reduced renal clearance. Some of them account for uremic problems such as reduced drug binding. Protein-bound organic acids such as hippuric acid, indoxyl sulfate, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), are markedly accumulated in uremic plasma, and produce defective protein binding of drugs. CMPF is tightly bound to serum albumin, and thus cannot be removed by conventional hemodialysis, but continuous ambulatory peritoneal dialysis and protein-leaking hemodialysis can remove CMPF, leading to lower serum levels. Based on the findings that indoxyl sulfate stimulates the progression of chronic renal failure in rats, and that low-protein diet or oral sorbent exert protective effects on the progression of chronic renal failure and reduce the serum and urine levels of indoxyl sulfate, the author proposes a protein metabolite hypothesis that endogenous protein metabolites such as indoxyl sulfate play a significant role in the progression of chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734460

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  19 in total

Review 1.  [Stewart's acid-base approach].

Authors:  Georg-Christian Funk
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

3.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions.

Authors:  P Sasi; M English; J Berkley; B Lowe; M Shebe; R Mwakesi; G Kokwaro
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10-27       Impact factor: 2.184

5.  The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores.

Authors:  Kajal P Patel; Frank J-G Luo; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

6.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Authors:  Björn K I Meijers; Henriette De Loor; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

7.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

8.  Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Authors:  Nhat M Pham; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 8.237

9.  Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate.

Authors:  E Banoglu; R S King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Apr-Jun       Impact factor: 2.441

Review 10.  Unmeasured anions in metabolic acidosis: unravelling the mystery.

Authors:  Lui G Forni; William McKinnon; Philip J Hilton
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.